Back
Roscan Gold Vs. Cidara Therapeutics Industry Stock Comparison
Sell
44
RCGCF
Roscan Gold
Last Price:
$0.06
Seasonality Move:
-13.02%
Buy
74
CDTX
Cidara Therapeutics
Last Price:
$50.58
Seasonality Move:
-8.55%
Sell
44
Roscan Gold (RCGCF)
is a Sell
Is Roscan Gold a Buy, Sell or Hold?
-
The current Roscan Gold [RCGCF] share price is $0.06. The Score for RCGCF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RCGCF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.88. The Score for CDTX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCGCF Stock Price Chart
What is Roscan Gold's stock price today?
-
The Roscan Gold share price today is $0.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCGCF is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
RCGCF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 62.52 | Buy |
Chaikin Money Flow: | 318428 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.05 - 0.05) | Buy |
Bollinger Bands (100): | (0.04 - 0.06) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.94 | Buy |
Relative Strength Index (14 RSI): | 78.66 | Buy |
Chaikin Money Flow: | 21664 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.13 - 49.33) | Buy |
Bollinger Bands (100): | (16.07 - 34.69) | Buy |
RCGCF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.05 | Buy |
20-day SMA: | 0.05 | Buy |
50-day SMA: | 0.05 | Buy |
200-day SMA: | 0.05 | Buy |
8-day EMA: | 0.01 | Buy |
20-day EMA: | 0.01 | Buy |
50-day EMA: | 0 | Buy |
200-day EMA: | 0 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.37 | Buy |
20-day SMA: | 39.67 | Buy |
50-day SMA: | 29.45 | Buy |
200-day SMA: | 21.42 | Buy |
8-day EMA: | 48.69 | Buy |
20-day EMA: | 42.07 | Buy |
50-day EMA: | 33.2 | Buy |
200-day EMA: | 23.39 | Buy |
Roscan Gold Earnings Growth & RCGCF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Roscan Gold Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |